ArticleScientific reports2022

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma.

Hongpan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.